Premature ovarian insufficiency: the context of long-term effects

A Podfigurna-Stopa, A Czyzyk, M Grymowicz… - Journal of …, 2016 - Springer
Purpose Premature ovarian insufficiency (POI) is defined as the cessation of the ovarian
function before the age of 40 years. POI aetiology may be related to iatrogenic or …

EMAS position statement: predictors of premature and early natural menopause

GD Mishra, HF Chung, A Cano, P Chedraui, DG Goulis… - Maturitas, 2019 - Elsevier
Introduction While the associations of genetic, reproductive and environmental factors with
the timing of natural menopause have been extensively investigated, few epidemiological …

EMAS position statement: the ten point guide to the integral management of menopausal health

M Neves-e-Castro, M Birkhauser, G Samsioe… - Maturitas, 2015 - Elsevier
With increased longevity and more women becoming centenarians, management of the
menopause and postreproductive health is of growing importance as it has the potential to …

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical …

N Mendoza, I Ramírez, E De la Viuda, P Coronado… - Maturitas, 2022 - Elsevier
This project aims to develop eligibility criteria for menopausal hormone therapy (MHT). The
tool should be similar to those already established for contraception A consortium of …

Pyrethroid pesticide exposure and risk of primary ovarian insufficiency in Chinese women

C Li, M Cao, L Ma, X Ye, Y Song, W Pan… - … science & technology, 2018 - ACS Publications
Pyrethroids are a class of widely used insecticides. Female animal studies suggested that
pyrethroid exposure impaired ovarian function, which resulted in similar symptoms of …

Menopause guideline appraisal and algorithm development for premature ovarian insufficiency

L Yeganeh, JA Boyle, A Wood, H Teede, AJ Vincent - Maturitas, 2019 - Elsevier
Abstract Objectives Clinical practice guidelines (CPGs) are systematically developed
statements that guide clinicians to provide appropriate healthcare. The aims of this study …

[HTML][HTML] Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study

A Tokmak, G Yıldırım, E Sarıkaya, M Çınar… - Revista Brasileira de …, 2015 - SciELO Brasil
PURPOSE: The aim of this study was to evaluate serum levels of inducible nitric oxide
synthase (INOS), myeloperoxidase (MPO), total antioxidant status (TAS), and total oxidative …

Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study

L Baquedano, A Espiau, M Fasero, S Ortega… - BMC Women's …, 2020 - Springer
Objective To study what women think about menopause treatments and assess their
knowledge about them. To analyze adherence to treatment during COVID-19 confinement …

Management of bone health in women with premature ovarian insufficiency: systematic appraisal of clinical practice guidelines and algorithm development

V Kiriakova, SD Cooray, L Yeganeh, G Somarajah… - Maturitas, 2019 - Elsevier
Background Osteoporosis is a key concern of women with premature ovarian insufficiency
(POI) but there are gaps in clinicians' knowledge of bone health. Objectives 1) To …

Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI)

K Szlendak-Sauer, D Jakubik, M Kunicki… - European Journal of …, 2016 - Elsevier
Objectives Autoimmune polyglandular syndrome type 3–(APS-3), is defined as the
coexistence of autoimmune thyroiditis with other non-ovarian autoimmune diseases without …